197 related articles for article (PubMed ID: 19001640)
1. Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance.
Tancred TM; Belch AR; Reiman T; Pilarski LM; Kirshner J
J Histochem Cytochem; 2009 Mar; 57(3):239-47. PubMed ID: 19001640
[TBL] [Abstract][Full Text] [Related]
2. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
4. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.
Glavey SV; Naba A; Manier S; Clauser K; Tahri S; Park J; Reagan MR; Moschetta M; Mishima Y; Gambella M; Rocci A; Sacco A; O'Dwyer ME; Asara JM; Palumbo A; Roccaro AM; Hynes RO; Ghobrial IM
Leukemia; 2017 Nov; 31(11):2426-2434. PubMed ID: 28344315
[TBL] [Abstract][Full Text] [Related]
5. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
Paiva B; Pérez-Andrés M; Vídriales MB; Almeida J; de las Heras N; Mateos MV; López-Corral L; Gutiérrez NC; Blanco J; Oriol A; Hernández MT; de Arriba F; de Coca AG; Terol MJ; de la Rubia J; González Y; Martín A; Sureda A; Schmidt-Hieber M; Schmitz A; Johnsen HE; Lahuerta JJ; Bladé J; San-Miguel JF; Orfao A; ;
Leukemia; 2011 Apr; 25(4):697-706. PubMed ID: 21252988
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin.
Malara A; Currao M; Gruppi C; Celesti G; Viarengo G; Buracchi C; Laghi L; Kaplan DL; Balduini A
Stem Cells; 2014 Apr; 32(4):926-37. PubMed ID: 24357118
[TBL] [Abstract][Full Text] [Related]
7. Expression of alpha-smooth muscle actin in the stromal cells of bone marrow in fetuses in different stages of development, in multiple myeloma and monoclonal gammopathy of unknown significance.
Tamiolakis D; Kotini A; Lambropoulou M; Tolparidou I; Papadopoulos N
Clin Exp Obstet Gynecol; 2002; 29(1):45-8. PubMed ID: 12013093
[TBL] [Abstract][Full Text] [Related]
8. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
[TBL] [Abstract][Full Text] [Related]
11. Characterization of bone marrow stromal cells from multiple myeloma.
Gregoretti MG; Gottardi D; Ghia P; Bergui L; Merico F; Marchisio PC; Caligaris-Cappio F
Leuk Res; 1994 Sep; 18(9):675-82. PubMed ID: 7934143
[TBL] [Abstract][Full Text] [Related]
12. CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features.
Schmidt-Hieber M; Pérez-Andrés M; Paiva B; Flores-Montero J; Perez JJ; Gutierrez NC; Vidriales MB; Matarraz S; San Miguel JF; Orfao A
Haematologica; 2011 Feb; 96(2):328-32. PubMed ID: 20971816
[TBL] [Abstract][Full Text] [Related]
13. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.
Ioannou MG; Stathakis E; Lazaris AC; Papathomas T; Tsiambas E; Koukoulis GK
Pathol Oncol Res; 2009 Mar; 15(1):25-9. PubMed ID: 18553158
[TBL] [Abstract][Full Text] [Related]
15. An atlas of the bone marrow bone proteome in patients with dysproteinemias.
Ho M; Dasari S; Visram A; Drake MT; Charlesworth MC; Johnson KL; Pujari GP; Jevremovic D; Kourelis T
Blood Cancer J; 2023 Apr; 13(1):63. PubMed ID: 37105956
[TBL] [Abstract][Full Text] [Related]
16. PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
Costa F; Vescovini R; Marchica V; Storti P; Notarfranchi L; Dalla Palma B; Toscani D; Burroughs-Garcia J; Catarozzo MT; Sammarelli G; Giuliani N
Front Immunol; 2020; 11():613007. PubMed ID: 33488620
[TBL] [Abstract][Full Text] [Related]
17. Expression of BAX in plasma cell dyscrasias.
Renner S; Weisz J; Krajewski S; Krajewska M; Reed JC; Lichtenstein A
Clin Cancer Res; 2000 Jun; 6(6):2371-80. PubMed ID: 10873089
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
Kline M; Donovan K; Wellik L; Lust C; Jin W; Moon-Tasson L; Xiong Y; Witzig TE; Kumar S; Rajkumar SV; Lust JA
Leuk Res; 2007 May; 31(5):591-8. PubMed ID: 16879867
[TBL] [Abstract][Full Text] [Related]
19. Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
Donovan KA; Lacy MQ; Kline MP; Ahmann GJ; Heimbach JK; Kyle RA; Lust JA
Leukemia; 1998 Apr; 12(4):593-600. PubMed ID: 9557619
[TBL] [Abstract][Full Text] [Related]
20. The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
Sidiqi MH; Aljama M; Kumar SK; Jevremovic D; Buadi FK; Warsame R; Lacy MQ; Dingli D; Gonsalves WI; Fonder AL; Hobbs MA; Hwa YL; Kapoor P; Kourelis T; Leung N; Muchtar E; Lust JA; Kyle RA; Go RS; Rajkumar VS; Gertz MA; Dispenzieri A
Blood Cancer J; 2020 May; 10(5):52. PubMed ID: 32376870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
